ALL Panel Cytogenetics FISH BCR/ABL TEL/AML1 MLL E2A Test
Comprehensive Genetic Analysis for Acute Lymphoblastic Leukemia
The ALL Panel Cytogenetics FISH test represents a cutting-edge diagnostic approach for acute lymphoblastic leukemia (ALL), combining traditional cytogenetic analysis with advanced molecular techniques. This comprehensive panel provides healthcare providers with critical genetic information essential for accurate diagnosis, prognosis assessment, and treatment planning in leukemia patients.
What This Test Measures and Detects
This specialized genetic panel utilizes multiple diagnostic methodologies to identify key genetic abnormalities associated with ALL:
- BCR/ABL Fusion Gene: Detects the Philadelphia chromosome translocation, a critical prognostic marker
- TEL/AML1 Rearrangement: Identifies the t(12;21) translocation common in pediatric ALL
- MLL Gene Abnormalities: Screens for mixed lineage leukemia gene rearrangements
- E2A Gene Disruptions: Detects abnormalities in the E2A transcription factor gene
- Cytogenetic Analysis: Examines chromosome structure and number for comprehensive assessment
Who Should Consider This Test
This advanced genetic panel is recommended for individuals presenting with:
- Suspected acute lymphoblastic leukemia based on clinical symptoms
- Unexplained fatigue, weakness, or persistent infections
- Easy bruising, bleeding, or petechiae (small red spots under the skin)
- Bone pain or joint discomfort
- Enlarged lymph nodes, liver, or spleen
- Fever without apparent cause
- Night sweats and unexplained weight loss
- Patients requiring treatment response monitoring
Clinical Benefits of ALL Panel Testing
Undergoing the ALL Panel Cytogenetics FISH test provides numerous clinical advantages:
- Precise Diagnosis: Enables accurate classification of leukemia subtypes
- Prognostic Information: Helps predict disease course and treatment response
- Personalized Treatment: Guides selection of targeted therapies based on genetic markers
- Minimal Residual Disease Monitoring: Allows detection of low-level disease after treatment
- Risk Stratification: Assists in determining appropriate treatment intensity
- Family Counseling: Provides information for genetic counseling when indicated
Understanding Your Test Results
Your ALL Panel results will provide detailed genetic information that your healthcare provider will interpret in clinical context:
- Normal Results: No significant genetic abnormalities detected
- BCR/ABL Positive: Indicates Philadelphia chromosome-positive ALL, requiring specific tyrosine kinase inhibitor therapy
- TEL/AML1 Rearrangement: Associated with favorable prognosis in pediatric ALL
- MLL Abnormalities: May indicate high-risk disease requiring intensive treatment
- Complex Cytogenetics: Multiple chromosomal abnormalities suggesting aggressive disease
Your oncologist will discuss the specific implications of your results and develop a personalized treatment plan based on the genetic findings.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $550 |
| Regular Price | $700 |
| Test Name | ALL Panel Cytogenetics FISH BCR/ABL TEL/AML1 MLL E2A |
| Turnaround Time | 10 days |
| Sample Type | Bone marrow / Peripheral blood (Transport immediately) |
| Test Components | Sodium Heparin Vacutainer (2ml) |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing results nationwide.
Book Your ALL Panel Test Today
Take the first step toward precise leukemia diagnosis and personalized treatment planning. Our genetic specialists are available to answer your questions and guide you through the testing process. Contact us today to schedule your ALL Panel Cytogenetics FISH test and receive the comprehensive genetic analysis you need for optimal care.
Call or WhatsApp: +1(267) 388-9828
Our experienced genetic counselors and oncology specialists are ready to assist you with scheduling, insurance questions, and result interpretation. Don’t wait – early genetic testing can significantly impact treatment outcomes in acute lymphoblastic leukemia.
